Kamada (KMDA) Gets FDA Approval for Rabies Vaccine
Kamada Ltd. KMDA and partner Kedrion Biopharma and announced that FDA has approved Kedrab [rabies immune globulin (Human)] for post-exposure prophylaxis against rabies infection. The company will launch Kedrab in the United States in early 2018 […]